CVS Buys Omnicare: What About the Buybacks?

Shares of CVS Health (CVS) has gained nearly 3% after the drugstore/pharmacy-benefits manager said it would buy Omnicare (OCR) for nearly $11 billion. Guggenheim’s John Heinbockel and Steven Forbes like the deal but note that it will come at the expense of stock buybacks. They explain: Associated Press We would remain buyers of CVS, as [...]
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.